ClinicalTrials.gg
RecruitingNCT05240846Updated Sep 6, 2023

Spinal Anesthesia Using Ultrasound Assistance Versus Conventional Palpation in Morbidly Obese Patients

An interventional study of Paramedian conventional palpation group and Ultrasound assistance paramedian spinal group in Spinal Anesthesia, Ultrasound Assistance and Obesity, Morbid, sponsored by Kafrelsheikh University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-09-06.

Sponsored by Kafrelsheikh University · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Primary completion was expected by Sep 2023, 3 years 2 months ago, but the record still lists the study as recruiting.
  • Started Feb 2022; still recruiting 4 years 8 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
64
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 76 studies in Obesity, Morbid with a site in Egypt — 12 open to participants now, 16 under way, none of them phase 3. Obesity, Morbid · Egypt.

Planned enrollment
46th of 69
64 · median 90
Started
2022
with 9 others
No phase
56 of 76
3 open now
Primary completion
2023-09
later than 0 of 15 live
Registered
33rd of 76
by date
Lead sponsor
3 of 76
Kafrelsheikh University

Among the 76 studies in Obesity, Morbid with a site in Egypt, this one is the 46th largest by planned enrollment of the 69 interventional ones that give a count, is one of 10 that started in 2022, is one of 56 with no phase, reaches primary completion later than 0 of the 15 other live ones, and was the 33rd registered.

Obesity, Morbid

941 studies on the registry are indexed under Obesity, Morbid; 162 are open to participants now.

Browse Obesity, Morbid studies →

Open to participants now

12 of the 76 studies in Obesity, Morbid with a site in Egypt are open now. Recruiting first, the newest first:

6 more — sign in →

All 12 open studies →

A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →

Who these studies take

Of the 109 Obesity, Morbid studies recruiting now, 21 (19%) set no upper age limit and 83 (76%) stop at 75 or younger; 8 take children under 18; 9 take healthy volunteers.

This study: 18 Years to 65 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 76 studies in Obesity, Morbid with a site in Egypt, or all of them as a file.
02

Study summary

The aim of this study is to compare the paramedian approach for spinal anesthesia using ultrasound assistance (USAS) versus conventional palpation in morbidly obese patients undergoing elective surgeries.

Read the detailed description

Performing spinal anesthesia using a conventional approach can be considerably challenging in obese patients. Multiple needle attempts may lead to a higher incidence of complications (e.g., postdural puncture headache, paresthesia, hematoma, and infection) and increase patient discomfort and dissatisfaction. Therefore, novel techniques are needed to improve the success rate of spinal anesthesia for such patients.

There are two puncture approaches for spinal anesthesia: median approach puncture and paramedian approach puncture. Early studies have noted that the success rate of paramedian approach puncture was higher than that of median approach puncture and that it is associated with fewer complications and postoperative complications.

A paramedian approach has been shown to improve the success rate of spinal anesthesia, especially in patients who are unable to sit up or those with a degenerative spine condition. The use of ultrasound has been suggested to increase the efficacy of spinal anesthesia.

Recently, ultrasound has emerged as a way to facilitate lumbar neuraxial blocks, namely, the ultrasound assistance (USAS) technique. The ultrasound assistance technique is beneficial for lumbar neuraxial anesthesia, improving technique performance by providing reliable anatomical information.

03

Conditions studied

  • Spinal Anesthesia
  • Ultrasound Assistance
  • Obesity, Morbid

Browse trials for

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Both sexes
  • (BMI) ≥ 40 kg/m2
  • Patients undergoing elective surgeries

Exclusion criteria

Exclusion Criteria:

  • Rejection of spinal anesthesia
  • History of spinal deformity or spinal surgery
  • to spinal anesthesia (infection of the puncture site, coagulation dysfunction, allergy to local anesthesia, insufficient blood volume or abnormal spinal anatomy).
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
64 participants (estimated)

Study arms

  • Experimental
    Paramedian conventional palpation group

    Patients in this group underwent conventional landmark guided paramedian spinal anesthetic. The spinal anesthesia will be administered based on conventional landmark-based paramedian approach.

    Procedure: Paramedian conventional palpation group

  • Experimental
    Ultrasound assistance paramedian spinal group

    This group will have their spinal anesthetic done based on Ultrasound assistance paramedian spinal.

    Procedure: Ultrasound assistance paramedian spinal group

Interventions

  • ProcedureParamedian conventional palpation group

    Patients in this group underwent conventional landmark guided paramedian spinal anesthetic. The spinal anesthesia will be administered based on conventional landmark-based paramedian approach.

  • ProcedureUltrasound assistance paramedian spinal group

    This group will have their spinal anesthetic done based on ultrasound assistance paramedian spinal. Spinal anesthesia with a paramedian approach was performed based on the optimum puncture point, suggested puncture angles, and puncture depth. The suggested puncture angles included the cephalad angle measured by the built-in angle program of the ultrasound and the medial angle measured by a 180° protractor (Deli). The puncture depth, the distance from the skin to the posterior complex, was measured utilizing the ultrasound clipper tool.

06

What researchers measure

Primary outcomes

  1. The rate of successful dural puncture on the first attempt

    First-attempt success rate will be recorded

    Time frame: Intraoperatively

Secondary outcomes

  1. Total success rate of spinal anesthesia

    Successful Dural Puncture Rates for Selected Number of Attempts and Passes in both intervention groups

    Time frame: Intraoperatively

  2. Adverse reactions during puncture

    Adverse reactions during puncture as incidence of nerve stimulation

    Time frame: Intraoperatively

  3. Complications after anesthesia

    Complications after anesthesia as incidence of low back pain

    Time frame: 24 hours Postoperative

  4. Patients' satisfaction after surgery

    6- Degree of patient satisfaction will be assessed on a 3-point scale; (1= unsatisfied 2= neither satisfied nor unsatisfied 3= satisfied)

    Time frame: 24 hours Postoperative

07

Study locations

1 of 1 sites recruiting
  • Kafr El-Sheikh University Hospitals
    Kafr Ash Shaykh, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — This study will be available upon a reasonable request from the corresponding author

Supporting information: Study protocol

Time frame: One year after the end of the study

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2022 (actual). Primary completion is estimated for Sep 2023, 18 months after the start.

Of 273 non-industry interventional studies with no phase under Obesity, Morbid, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 48. This study's planned 18 months is below that.

Counting every sponsor, half of 285 studies reached it within 25 months; a quarter within 11 and three quarters within 48.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 4, 2022
First posted
Feb 15, 2022
StartActual
Feb 23, 2022
Primary completionEst.
Sep 20, 2023
CompletionEst.
Sep 20, 2023
Last update
Sep 6, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 6, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05240846
Responsible party
Mohamed Fouad Algyar (Doctor, Kafrelsheikh University) — Principal investigator
First posted
Feb 15, 2022
Start date
Feb 23, 2022
Primary completion
Sep 20, 2023 (estimated)
Completion
Sep 20, 2023 (estimated)
Last update
Sep 6, 2023

Study contacts

Mohammad Algyar, MD
Contact
mohammad.algaiar@med.kfs.edu.eg
0111645345 ext. +2

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion